Jack Sh Chen

Jack SH Chen is a seasoned scientific director with extensive experience in translational oncology and precision medicine, currently leading efforts at AbbVie since January 2022. With a strong background in managing complex oncology programs and mentoring R&D teams, Jack has successfully advanced multiple assets through clinical development. Prior roles include significant contributions at Pfizer, OncoMed Pharmaceuticals, Eli Lilly, and The Johns Hopkins University, demonstrating expertise in cancer immunology, biomarker identification, and strategies for patient selection. Jack holds a Ph.D. in Oncology & Immunology from The Johns Hopkins University and an MS in Biochemistry & Cancer Biology from National Taiwan University.